Farmer Michele 4

What Happened
Michele Farmer, Chief Accounting Officer of Pacific Biosciences (PACB), was granted equity awards on February 27, 2026: 89,835 shares represented by Restricted Stock Units (RSUs) and 179,670 derivative shares (option-style award). Both awards were reported at $0.00 per share (no cash paid). Total awarded shares equal 269,505. These are compensatory awards (not open-market purchases or sales).

Key Details

• Transaction date: 2026-02-27; Form 4 filed 2026-03-03 (filing appears timely).
• Awards: 89,835 RSUs (grant at $0.00) and 179,670 derivative shares (grant at $0.00). Combined = 269,505 shares.
• Vesting:
  • RSUs (89,835): vest in equal annual installments on Feb 15 of 2027, 2028 and 2029 (F1).
  • Derivative/option award (179,670): vests in 36 equal monthly installments beginning March 27, 2026 (F2).
• Shares owned after the transaction: not specified in this filing.
• Transaction type codes: A = Award/Grant; derivative entry denotes an option-type award.
• No cash exchanged (price = $0.00); these are compensation grants, not purchases or sales.

Context
These grants are typical executive compensation awards intended to retain and incentivize the officer over multiple years via vesting schedules. As awards (not immediate sales or purchases), they do not by themselves indicate a near-term trading intent. The derivative award’s monthly vesting means portions will become exercisable/vest over three years beginning March 27, 2026.